GlassScriptPhysician profile
Bruce R Barton
NPI 1912058132
$1,352.51
in general payments reported to CMS, 2019-2025
13 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $307 · 2021: $11.32 · 2022: $379 · 2024: $16.18 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $421.29 | 2019-2025 | Dupixent |
| Sientra, INC. | $196.65 | 2019-2022 | |
| Amgen INC. | $123.01 | 2020 | |
| Celgene Corporation | $110.85 | 2019 | |
| Sun Pharmaceutical Industries INC. | $108.76 | 2022 | |
| Incyte Corporation | $100.70 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $99.99 | 2020 | |
| Pfizer INC. | $85.68 | 2019 | |
| Merz North America, INC. | $28.45 | 2020-2021 | |
| Galderma Laboratories, L.P. | $27.62 | 2020 | |
| Genzyme Corporation | $21.47 | 2022 | |
| Ucb, INC. | $16.54 | 2019 | |
| Biodelivery Sciences International, INC. | $11.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.